Sentinel lymph node mapping for early-stage ovarian cancer surgery
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a technique to find the first lymph nodes that might contain cancer cells during surgery for early-stage ovarian cancer. It aims to see if this method can help doctors remove fewer lymph nodes while still getting important information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 90 years old.
- You are having surgery to remove an ovarian mass or tumor.
- The tumor is found to be cancerous or borderline (not fully cancerous) during surgery.
- Your cancer is early-stage, meaning it has not spread to other parts of your body.
- You have not had lymph nodes removed in a previous surgery.
- You are not allergic to indocyanine green (a dye used in the procedure) or iodine.
- You are not pregnant and have no history of radiation therapy or other cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a technique that uses a special dye to find the first lymph nodes where ovarian cancer might spread. It aims to help doctors remove only those sentinel nodes during surgery instead of removing many nodes, which could lead to fewer side effects.
This study tests a way to check for cancer spread in the lymph nodes of the pelvis during surgery for early-stage ovarian cancer. It uses a special dye and tracer to find the first lymph node that drains from the tumor.
This study checks whether doctors can find the first lymph node(s) where ovarian cancer may spread using two dyes (a radioactive tracer and a green dye). It may help surgeons do more precise staging and treatment planning.
This trial tests whether injecting a dye called indocyanine green (ICG) in different spots can better find sentinel lymph nodes during surgery for endometrial cancer. It may help doctors remove fewer nodes and reduce side effects.
This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.